Roles of nitric oxide and asymmetric dimethylarginine in pregnancy and fetal programming

International Journal of Molecular Sciences

Volumn 13, Issue 11, 2012, Pages 14606-14622

  Huang, Li Tung ^a,b   Hsieh, Chih Sung ^c,d   Chang, Kow Aung ^a   Tain, You Lin ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c PINGTUNG CHRISTIAN HOSPITAL   (Taiwan)

^d MEIHO UNIVERSITY   (Taiwan)

Author keywords

Asymmetric dimethylarginine; Fetal programming; Nitrergic; Nitric oxide; Placenta

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; AMINO ACID TRANSPORTER; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIOXIDANT; ARGININE; CITRULLINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FENOFIBRATE; FOLIC ACID; GLUCOCORTICOID; INDUCIBLE NITRIC OXIDE SYNTHASE; MELATONIN; METFORMIN; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; ORAL CONTRACEPTIVE AGENT; THIOCTIC ACID; VASCULOTROPIN; N,N-DIMETHYLARGININE;

ANGIOGENESIS; BLOOD VESSEL REACTIVITY; BRAIN HEMORRHAGE; EMBRYO DEVELOPMENT; ENDOTHELIAL DYSFUNCTION; EPIGENETICS; FETOPLACENTAL UNIT; FETUS DEVELOPMENT; FETUS GROWTH; FETUS OUTCOME; GESTATION PERIOD; HUMAN; MALNUTRITION; NONHUMAN; PERINATAL STRESS; PLACENTA CIRCULATION; PLACENTA INSUFFICIENCY; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREMATURITY; PRENATAL PERIOD; PROTEIN EXPRESSION; PROTEIN METABOLISM; RESPIRATORY DISTRESS; REVIEW; UTERINE ARTERY; VASCULAR ENDOTHELIUM; VASODILATATION; ANALOGS AND DERIVATIVES; ANIMAL; DRUG EFFECTS; FEMALE; METABOLISM; PHYSIOLOGY; PLACENTA; PREGNANCY COMPLICATION; PRENATAL EXPOSURE;

ANIMALS; ARGININE; FEMALE; FETAL DEVELOPMENT; HUMANS; METABOLIC NETWORKS AND PATHWAYS; NITRIC OXIDE; PLACENTA; PLACENTAL INSUFFICIENCY; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 84871026209     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms131114606     Document Type: Review

References (98)

1. Myatt, L. Placental adaptive responses and fetal programming. J. Physiol. 2006, 572, 25-30.
2. Reynolds, L.P.; Borowicz, P.P.; Caton, J.S.; Vonnahme, K.A.; Luther, J.S.; Buchanan, D.S.; Hafez, S.A.; Grazul-Bilska, A.T.; Redmer, D.A. Uteroplacental vascular development and placental function: an update. Int. J. Dev. Biol. 2010, 54, 355-366.
3. Krause, B.J.; Hanson, M.A.; Casanello, P. Role of nitric oxide in placental vascular development and function. Placenta 2011, 32, 797-805.
4. Godfrey, M. The role of the placenta in fetal programming-A review. Placenta 2002, 23, S20-S27.
5. Reynolds, L.P.; Caton, J.S.; Redmer, D.A.; Grazul-Bilska, A.T.; Vonnahme, K.A.; Borowicz, P.P.; Luther, J.S.; Wallace, J.M.; Wu, G.; Spencer, T.E. Evidence for altered placental blood flow and vascularity in compromised pregnancies. J. Physiol. 2006, 572, 51-58.
6. Vallance, P.; Leiper, J. Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway. Arterioscler. Thromb. Vasc. Biol. 2004, 24, 1023-1030.
7. Teerlink, T.; Luo, Z.; Palm, F.; Wilcox, C.S. Cellular ADMA: Regulation and action. Pharmacol. Res. 2009, 60, 448-460.
8. Sibal, L.; Agarwal, S.C.; Home, P.D.; Boger, R.H. The role of asymmetric dimethylarginine (ADMA) in endothelial dysfunction and cardiovascular disease. Curr. Cardiol. Rev. 2010, 6, 82-90.
9. Fickling, S.A.; Williams, D.; Vallance, P.; Nussey, S.S.; Whitley, G.S. Plasma of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and pre-eclampsia. Lancet 1993, 342, 242-243.
10. Holden, D.P.; Fickling, S.A.; Whitley, G.S.; Nussey, S.S. Plasma concentrations of asymmetric dimethylarginine, a natural inhibitor of nitric oxide synthase, in normal pregnancy and preeclampsia. Am. J. Obstet. Gynecol. 1998, 178, 551-556.
11. Jansson, T.; Powell, T.L. Role of the placenta in fetal programming: Underlying mechanisms and potential interventional approaches. Clin. Sci. (Lond.) 2007, 113, 1-13.
12. Reynolds, L.P.; Caton, J.S. Role of the pre-and post-natal environment in developmental programming of health and productivity. Mol. Cell Endocrinol. 2012, 354, 54-59.
13. Rugg-Gunn, P.J. Epigenetic features of the mouse trophoblast. Reprod. Biomed. Online 2012, 25, 21-30.
14. Illi, B.; Colussi, C.; Grasselli, A.; Farsetti, A.; Capogrossi, M.C.; Gaetano, C. NO sparks off chromatin: Tales of a multifaceted epigenetic regulator. Pharmacol. Ther. 2009, 123, 344-352.
15. Nott, A.; Riccio, A. Nitric oxide-mediated epigenetic mechanisms in developing neurons. Cell Cycle 2009, 8, 725-730.
16. Tain, Y.L.; Huang, L.T. Asymmetric dimethylarginine: Clinical applications in pediatric medicine. J. Formos. Med. Assoc. 2011, 110, 70-77.
17. Vida, G.; Sulyok, E.; Ertl, T.; Martens-Lobenhoffer, J.; Bode-Boger, S.M. Plasma asymmetric dimethylarginine concentration during the perinatal period. Neonatology 2007, 92, 8-13.
18. Lucke, T.; Kanzelmeyer, N.; Kemper, M.J.; Tsikas, D.; Das, A.M. Developmental changes in the L-arginine/nitric oxide pathway from infancy to adulthood: Plasma asymmetric dimethylarginine levels decrease with age. Clin. Chem. Lab. Med. 2007, 45, 1525-1530.
19. Horowitz, J.D.; Heresztyn, T. An overview of plasma concentrations of asymmetric dimethylarginine (ADMA) in health and disease and in clinical studies: Methodological considerations. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2007, 851, 42-50.
20. Rossmanith, W.G.; Hoffmeister, U.; Wolfahrt, S.; Kleine, B.; McLean, M.; Jacobs, R.A.; Grossman, A.B. Expression and functional analysis of endothelial nitric oxide synthase (eNOS) in human placenta. Mol. Hum. Reprod. 1999, 5, 487-494.
21. Ariel, I.; Hochberg, A.; Shochina, M. Endothelial nitric oxide synthase immunoreactivity in early gestation and in trophoblastic disease. J. Clin. Pathol. 1998, 51, 427-431.
22. Suzuki, T.; Ikeda, Y.; Yoshikawa, H.; Tanaka, K.; Morita, H.; Yamamoto, M.; Takizawa, T. Gestational changes in production of NO and expression of NOS mRNA isoforms in the rat placenta. J. Vet. Med. Sci. 2009, 71, 495-498.
23. Suzuki, T.; Mori, C.; Yoshikawa, H.; Miyazaki, Y.; Kansaku, N.; Tanaka, K.; Morita, H.; Takizawa, T. Changes in nitric oxide production levels and expression of nitric oxide synthase isoforms in the rat uterus during pregnancy. Biosci. Biotechnol. Biochem. 2009, 73, 2163-2166.
24. Purcell, T.L.; Given, R.; Chwalisz, K.; Garfield, R.E. Nitric oxide synthase distribution during implantation in the mouse. Mol. Hum. Reprod. 1999, 5, 467-475.
25. Seligman, S.P.; Buyon, J.P.; Clancy, R.M.; Young, B.K.; Abramson, S.B. The role of nitric oxide in the pathogenesis of preeclampsia. Am. J. Obstet. Gynecol. 1994, 171, 944-948.
26. Xiao, D.; Pearce, W.; Zhang, L. Pregnancy enhances endothelium-dependent relaxation of ovine uterine artery: Role of NO and intracellular Ca2+. Am. J. Physiol. Heart Circ. Physiol. 2001, 281, H183-H190.
27. Kaufmann, P.; Mayhew, T.M.; Charnock-Jones, D.S. Aspects of human fetoplacental vasculogenesis and angiogenesis. II. Changes during normal pregnancy. Placenta 2004, 25, 114-126.
28. Demir, R.; Kayisli, U.A.; Cayli, S.; Huppertz, B. Sequential steps during vasculogenesis and angiogenesis in the very early human placenta Placenta 2006, 27, 535-539.
29. Shizukuda, Y.; Tang, S.; Yokota, R.; Ware, J.A. Vascular endothelial growth factor-induced endothelial cell migration and proliferation depend on a nitric oxide-mediated decrease in protein kinase C activity. Circ. Res. 1999, 85, 247-256.
30. Nath, A.K.; Enciso, J.; Kuniyasu, M.; Hao, X.Y.; Madri, J.A.; Pinter, E. Nitric oxide modulates murine yolk sac vasculogenesis and rescues glucose induced vasculopathy. Development 2004, 131, 2485-2496.
31. Frank, S.; Stallmeyer, B.; Kampfer, H.; Schaffner, C.; Pfeilschifter, J. Differential regulation of vascular endothelial growth factor and its receptor fms-like-tyrosine kinase is mediated by nitric oxide in rat renal mesangial cells. Biochem. J. 1999, 338, 367-374.
32. Han, R.N.; Stewart, D.J. Defective lung vascular development in endothelial nitric oxide synthasedeficient mice. Trends Cardiovasc. Med. 2006, 16, 29-34.
33. Zhao, X.; Lu, X.; Feng, Q. Deficiency in endothelial nitric oxide synthase impairs myocardial angiogenesis. Am. J. Physiol. Heart Circ. Physiol. 2002, 283, H2371-H2378.
34. Kon, K.; Fujii, S.; Kosaka, H.; Fujiwara, T. Nitric oxide synthase inhibition by N(G)-nitro-L-arginine methyl ester retards vascular sprouting in angiogenesis. Microvasc. Res. 2003, 65, 2-8.
35. Dulak, A.; Jozkowicz, J. Regulation of vascular endothelial growth factor synthesis by nitric oxide: Facts and controversies. Antioxid. Redox. Signal 2003, 5, 123-132.
36. Vida, G.; Sulyok, E.; Ertl, T.; Martens-Lobenhoffer, J.; Bode-Böger, S.M. Birth by cesarean section is associated with elevated neonatal plasma levels of dimethylarginines. Pediatr. Int. 2012, 54, 476-479.
37. Reynolds, L.P.; Borowicz, P.P.; Vonnahme, K.A.; Johnson, M.L.; Grazul-Bilska, A.T.; Wallace, J.M.; Caton, J.S.; Redmer, D.A. Animal models of placental angiogenesis. Placenta 2005, 26, 689-708.
38. Myatt, L. Review: Reactive oxygen and nitrogen species and functional adaptation of the placenta. Placenta 2010, 24, S66-S69.
39. Vonnahme, K.A.; Wilson, M.E.; Li, Y.; Rupnow, H.L.; Phernetton, T.M.; Ford, S.P.; Magness, R.R. Circulating levels of nitric oxide and vascular endothelial growth factor throughout ovine pregnancy. J. Physiol. 2005, 565, 101-109.
40. Reynolds, L.P.; Redmer, D.A. Angiogenesis in the placenta. Biol. Reprod. 2001, 64, 1033-1040.
41. Bird, I.M.; Zhang, L.; Magness, R.R. Possible mechanisms underlying pregnancy-induced changes in uterine artery endothelial function. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003, 284, R245-R258.
42. Khullar, S.; Greenwood, S.L.; McCord, N.; Glazier, J.D.; Ayuk, P.T. Nitric oxide and superoxide impair human placental amino acid uptake and increase Na+ permeability: Implications for fetal growth. Free Radic. Biol. Med. 2004, 36, 271-277.
43. Kossenjans, W.; Eis, A.; Sahay, R.; Brockman, D.; Myatt, L. Role of peroxynitrite in altered fetal-placental vascular reactivity in diabetes or preeclampsia. Am. J. Physiol. Heart Circ. Physiol. 2000, 278, H1311-H1139.
44. Roberts, V.H.; Webster, R.P.; Brockman, D.E.; Pitzer, B.A.; Myatt, L. Post-translational modifications of the P2X(4) purinergic receptor subtype in the human placenta are altered in preeclampsia. Placenta 2007, 28, 270-277.
45. Webster, R.P.; Macha, S.; Brockman, D.; Myatt, L. Peroxynitrite treatment in vitro disables catalytic activity of recombinant p38 MAPK. Proteomics 2006, 6, 4838-4844.
46. Savvidou, M.D.; Hingorani, A.D.; Tsikas, D.; Frolich, J.C.; Vallance, P.; Nicolaides, K.H. Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet 2003, 361, 1511-1517.
47. McCarthy, A.L.; Woolfson, R.G.; Evans, B.J.; Davies, D.R.; Raju, S.K.; Poston, L. Functional characteristics of small placental arteries. Am. J. Obstet. Gynecol. 1994, 170, 945-951.
48. Chang, J.K.; Roman, C.; Heymann, M.A. Effect of endothelium-derived relaxing factor inhibition on the umbilical-placental circulation in fetal lambs in utero. Am. J. Obstet. Gynecol. 1992, 166, 727-734.
49. Suzuki, T.; Nagamatsu, C.; Kushima, T.; Miyakoshi, R.; Tanaka, K.; Morita, H.; Sakaue, M.; Takizawa, T. Apoptosis caused by an inhibitor of NO production in the decidua of rat from mid-gestation. Exp. Biol. Med. (Maywood) 2010, 235, 455-462.
50. Lowe, D.T. Nitric oxide dysfunction in the pathophysiology of preeclampsia. Nitric Oxide 2000, 4, 441-458.
51. Baylis, C.; Beinder, E.; Suto, T.; August, P. Recent insights into the roles of nitric oxide and renin-angiotensin in the pathophysiology of preeclamptic pregnancy. Semin. Nephrol. 1998, 18, 208-230.
52. Noris, M.; Todeschini, M.; Cassis, P.; Pasta, F.; Cappellini, A.; Bonazzola, S.; Macconi, D.; Maucci, R.; Porrati, F.; Benigni, A.; et al. L-arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant species. Hypertension 2004, 43, 614-622.
53. Myatt, L.; Eis, A.L.; Brockman, D.E.; Kossenjans, W.; Greer, I.A.; Lyall, F. Endothelial nitric oxide in placental villous tissue from normal, pre-eclamptic and intrauterine restricted pregnancies. Hum. Reprod. 1997, 12, 714-718.
54. Leiper, J.; MacAllister, R.; Whitley, G.; Santa Maria, J.; Chubb, A.; Charles, I.; Vallance, P. Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology to microbial arginine deiminases. Biochem. J. 1999, 343, 209-214.
55. Anderssohn, M.; Maass, L.M.; Diemert, A.; Lüneburg, N.; Atzler, D.; Hecher, K.; Böger, R.H. Severely decreased activity of placental dimethylarginine dimethylaminohydrolase in pre-eclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol. 2012, 161, 152-156.
56. Akbar, F.; Heinonen, S.; Pirskanen, M.; Uimari, P.; Tuomainen, T.P.; Salonen, J.T. Haplotypic association of DDAH1 with susceptibility to pre-eclampsia. Mol. Hum. Reprod. 2005, 11, 73-77.
57. Kim, Y.J.; Park, B.H.; Park, H.; Jung, S.C.; Pang, M.G.; Ryu, H.M.; Lee, K.S.; Eom, S.M.; Park, H.Y. No association of the genetic polymorphisms of endothelial nitric oxide synthase, dimethylarginine dimethylaminohydrolase, and vascular endothelial growth factor with preeclampsia in Korean populations. Twin Res. Hum. Genet. 2008, 11, 77-83.
58. Sobrevia, L.; Mann, G.E. Dysfunction of the endothelial nitric oxide signalling pathway in diabetes and hyperglycaemia. Exp. Physiol. 1997, 82, 423-452.
59. Kucuk, M.; Doymaz, F. Placental weight and placental weight-to-birth weight ratio are increased in diet-and exercise-treated gestational diabetes mellitus subjects but not in subjects with one abnormal value on 100-g oral glucose tolerance test. J. Diabetes Complicat. 2009, 23, 25-31.
60. Daskalakis, G.; Marinopoulos, S.; Krielesi, V.; Papapanagiotou, A.; Papantoniou, N.; Mesogitis, S.; Antsaklis, A. Placental pathology in women with gestational diabetes. Acta. Obstet. Gynecol. Scand. 2008, 87, 403-407.
61. Sobrevia, L.; Abarzúa, F.; Nien, J.K.; Salomón, C.; Westermeier, F.; Puebla, C.; Cifuentes, F.; Guzmán-Gutiérrez, E.; Leiva, A.; Casanello, P. Review: Differential placental macrovascular and microvascular endothelial dysfunction in gestational diabetes. Placenta 2011, 25, S159-S164.
62. Figueroa, R.; Martinez, E.; Fayngersh, R.P.; Tejani, N.; Mohazzab-H., K.M.; Wolin, M.S. Alterations in relaxation to lactate and H2O2 in human placental vessels from gestational diabetic pregnancies. Am. J. Physiol. 2000, 278, H706-H713.
63. Farías, M.; Puebla, C.; Westermeier, F.; Jo, M.J.; Pastor-Anglada, M.; Casanello, P.; Sobrevia, L. Nitric oxide reduces SLC29A1 promoter activity and adenosine transport involving transcription factor complex hCHOP-C/EBPα in human umbilical vein endothelial cells from gestational diabetes. Cardiovas. Res. 2010, 86, 45-54.
64. Vásquez, G.; Sanhueza, F.; Vásquez, R.; González, M.; San Martín, R.; Casanello, P.; Sobrevia, L. Role of adenosine transport in gestational diabetes-induced L-arginine transport and nitric oxide synthesis in human umbilical vein endothelium. J. Physiol. 2004, 560, 111-122.
65. Stojanovic, N.; Lewandowski, K.; Salata, I.; Bienkiewicz, M.; Tuck, S.; Prelevic, G.; Press, M. Serum levels of matrix metalloproteinases MMP-2 and MMP-9 and their inhibitors in women with glucose intolerance in pregnancy and normal controls. Gynecol. Endocrinol. 2010, 26, 201-207.
66. Novaro, V.; Colman-Lerner, A.; Ortega, F.V.; Jawerbaum, A.; Paz, D.; Lo Nostro, F.; Pustovrh, C.; Gimeno, M.F.; González, E. Regulation of metalloproteinases by nitric oxide in human trophoblast cells in culture. Reprod. Fertil. Dev. 2001, 13, 411-420.
67. Akturk, M.; Altinova, A.; Mert, I.; Dincel, A.; Sargin, A.; Buyukkagnici, U.; Arslan, M.; Danisman, N. Asymmetric dimethylarginine concentrations are elevated in women with gestational diabetes. Endocrine 2010, 38, 134-141.
68. Wu, G.; Pond, W.G.; Flynn, S.P.; Ott, T.L.; Bazer, F.W. Maternal dietary protein deficiency decreases nitric oxide synthase and ornithine decarboxylase activities in placenta and endometrium of pigs during early gestation. J. Nutr. 1998, 128, 2395-2402.
69. Kwon, H.; Ford, S.P.; Bazer, F.W.; Spencer, T.E.; Nthanielsz, P.W.; Nijland, M.J.; Hess, B.W.; Wu, G. Maternal undernutrition reduces concentrations of amino acids and polyamines in ovine fetal plasma and fluids. Biol. Reprod. 2004, 71, 901-908.
70. Ozaki, T.; Hawkins, P.; Nishina, H.; Steyn, C.; Poston, L.; Hanson, M.A. Effects of undernutrition in early pregnancy on systemic small artery function in late-gestation fetal sheep. Am. J. Obstet. Gynecol. 2000, 183, 1301-1307.
71. Redmer, D.A.; Wallace, J.M.; Reynolds, L.P. Effect of nutrient intake during pregnancy on fetal and placental growth and vascular development. Domest. Anim. Endocrinol. 2004, 27, 199-217.
72. Hood, J.D.; Meininger, C.J.; Ziche, M.; Granger, H.J. VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. Am. J. Physiol. 1998, 274, H1054-H1058.
73. Babaei, S.; Teichert-Kuliszewska, K.; Monge, J.C.; Mohamed, F.; Bendeck, M.P.; Stewart, D.J. Role of nitric oxide in the angiogenic response in vitro to basic fibroblast growth factor. Circ. Res. 1998, 18, 1007-1015.
74. Rutland, C.S.; Latunde-Dada, A.O.; Thorpe, A.; Plant, R.; Langley-Evans, S.; Leach, L. Effect of gestational nutrition on vascular integrity in the murine placenta. Placenta 2007, 28, 734-742.
75. Tain, Y.L.; Hsieh, C.S.; Lin, I.C.; Chen, C.C.; Sheen, J.M.; Huang, L.T. Effects of maternal L-citrulline supplementation on renal function and blood pressure in offspring exposed to maternal caloric restriction: The impact of nitric oxide pathway. Nitric Oxide 2010, 23, 34-41.
76. Polyakov, A.; Cohen, S.; Baum, M.; Trickey, D.; Jolley, D.; Wallace, E.M. Patterns of antenatal corticosteroid prescribing 1998-2004. Aust. N. Z. J. Obstet. Gynaecol. 2007, 47, 42-45.
77. Huang, L.T. The link between perinatal glucocorticoids exposure and psychiatric disorders. Pediatr. Res. 2011, 69, 19R-25R.
78. Lui, C.C.; Wang, J.Y.; Tain, Y.L.; Chen, Y.C.; Chang, K.A.; Lai, M.C.; Huang, L.T. Prenatal stress in rat causes long-term spatial memory deficit and hippocampus MRI abnormality: Differential effects of postweaning enriched environment. Neurochem. Int. 2011, 58, 434-441.
79. Hewitt, D.P.; Mark, P.J.; Waddell, B.J. Glucocorticoids prevent the normal increase in placental vascular endothelial growth factor expression and placental vascularity during late pregnancy in the rat. Endocrinology 2006, 147, 5566-5574.
80. Parenti, A.; Morbidelli, L.; Cui, X.L.; Douglas, J.G.; Hood, J.D.; Granger, H.J.; Ledda, F.; Ziche, M. Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase1/2 activation in postcapillary endothelium. J. Biol. Chem. 1998, 273, 4220-4226.
81. Fukumura, D.; Gohongi, T.; Kadambi, A.; Izumi, Y.; Ang, J.; Yun, C.O.; Buerk, D.G.; Huang, P.L.; Jain, R.K. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc. Natl. Acad. Sci. USA 2001, 98, 2604-2609.
82. Bussolati, B.; Dunk, C.; Grohman, M.; Kontos, C.D.; Mason, J.; Ahmed, A. Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide. Am. J. Pathol. 2001, 159, 993-1008.
83. Kroll, J.; Waltenberger, J. VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR). Biochem. Biophys. Res. Commun. 1998, 252, 743-746.
84. Ribatti, D.; Nico, B.; Crivellato, E. Morphological and molecular aspects of physiological vascular morphogenesis. Angiogenesis 2009, 12, 101-111.
85. Rössig, L.; Li, H.; Fisslthaler, B.; Urbich, C.; Fleming, I.; Förstermann, U.; Zeiher, A.M.; Dimmeler, S. Inhibitors of histone deacetylation downregulate the expression of endothelial nitric oxide synthase and compromise endothelial cell function in vasorelaxation and angiogenesis. Circ. Res. 2002, 91, 837-844.
86. Zeng, L.; Xiao, Q.; Margariti, A.; Zhang, Z.; Zampetaki, A.; Patel, S.; Capogrossi, M.C.; Hu, Y.; Xu, Q. HDAC3 is crucial in shear-and VEGF-induced stem cell differentiation toward endothelial cells. J. Cell Biol. 2006, 174, 1059-1069.
87. Kuhn, P.; Xu, W. Protein arginine methyltransferases: Nuclear receptor coregulators and beyond. Prog. Mol. Biol. Transl. Sci. 2009, 87, 299-342.
88. Chen, W.; Cao, M.; Yang, Y.; Nagahama, Y.; Zhao, H. Expression pattern of prmt5 in adult fish and embryos of medaka, Oryzias latipes. Fish Physiol. Biochem. 2009, 35, 325-332.
89. Tain, Y.L.; Huang, L.T.; Lin, I.C.; Lau, Y.T.; Lin, C.Y. Melatonin prevents hypertension and increased asymmetric dimethylarginine in young spontaneous hypertensive rats. J. Pineal Res. 2010, 49, 390-398.
90. Piecha, G.; Koleganova, N.; Ritz, E.; Müller, A.; Fedorova, O.V.; Bagrov, A.Y.; Lutz, D.; Schirmacher, P.; Gross-Weissmann, M.L. High salt intake causes adverse fetal programming-vascular effects beyond blood pressure. Nephrol. Dial. Transplant. 2012, 27, 3464-3476.
91. Tain, Y.L.; Freshour, G.; Dikalova, A.; Griendling, K.; Baylis, C. Vitamin E reduces glomerulosclerosis, restores renal neuronal NOS, and suppresses oxidative stress in the 5/6 nephrectomized rat. Am. J. Physiol. Renal Physiol. 2007, 292, F1404-F1410.
92. Tain, Y.L.; Kao, Y.H.; Hsieh, C.S.; Chen, C.C.; Sheen, J.M.; Lin, I.C.; Huang, L.T. Melatonin blocks oxidative stress-induced increased asymmetric dimethylarginine. Free Radic. Biol. Med. 2010, 49, 1088-1098.
93. Germain, A.M.; Valdés, G.; Romanik, M.C.; Reyes, M.S. Evidence supporting a beneficial role for long-term L-arginine supplementation in high-risk pregnancies. Hypertension 2004, 44, e1.
94. Cynober, L.; Moinard, C.; De Bandt, J.P. The 2009 ESPEN Sir David Cuthbertson. Citrulline: A new major signaling molecule or just another player in the pharmaconutrition game? Clin. Nutr. 2010, 29, 545-551.
95. Prieto, C.P.; Krause, B.J.; Quezada, C.; San Martin, R.; Sobrevia, L.; Casanello, P. Hypoxia-reduced nitric oxide synthase activity is partially explained by higher arginase-2 activity and cellular redistribution in human umbilical vein endothelium. Placenta 2011, 32, 932-940.
96. Miller, S.L.; Wallace, E.M.; Walker, D.W. Antioxidant Therapies: A potential role in perinatal medicine. Neuroendocrinology 2012, 96, 13-23.
97. Dennery, P.A. Oxidative stress in development: nature or nurture? Free Radic. Biol. Med. 2010, 49, 1147-1151.
98. Rumbold, A.; Duley, L.; Crowther, C.A.; Haslam, R.R. Antioxidants for preventing pre-eclampsia. Cochrane Database Syst. Rev. 2008, 1, doi:10.1002/14651858.CD004227.pub3.